Fig. 1From: The acceleration of glucose accumulation in renal cell carcinoma assessed by FDG PET/CT demonstrated acquisition of resistance to tyrosine kinase inhibitor therapyPatient disposition of this clinical trial monitoring renal cell carcinoma by FDG PET/CT during TKI treatment until tumor demonstrated progression diseaseBack to article page